Background: The World Health Organization HEARTS Technical Package is a widely implemented global initiative to improve the primary care management of cardiovascular disease risk factors. The study’s objective is to report outcomes from a pilot implementation trial of integrated hypertension and diabetes management based on the HEARTS model in Guatemala. Methods: We conducted a single-arm pilot implementation trial over six months from October 2023 to May 2024 in 11 Guatemalan Ministry of Health primary care facilities in two districts. The pilot evaluated a package of five HEARTS-aligned implementation strategies to improve the pharmacological treatment of hypertension and diabetes. The primary outcomes were feasibility and acceptability, measured through 20 structured interviews with Ministry of Health employees and by examining enrolment and retention data. Secondary outcomes included a suite of implementation and clinical outcomes, including treatment rates. When baseline data were available, we analyzed secondary outcomes as the net change from baseline or using an interrupted time series approach. Results: The study enrolled 964 patients, of whom 58.8% had hypertension only, 30.4% had diabetes only, and 10.8% had both conditions. Surveys on feasibility and acceptability among Ministry of Health staff had a median score of 5.0 (IQR: 5.0 to 5.0) and 5.0 (IQR range: 4.8 to 5.0), respectively, exceeding the prespecified benchmark of ≥3.5. Both districts achieved the prespecified benchmark of enrolling ≥25 hypertension patients and ≥25 diabetes patients. Only 36% of patients attended a follow-up visit within three months, lower than the prespecified benchmark of ≥75%. Monthly treatment rates during the pilot increased by 22.3 (95% CI: 16.2 to 28.4; P < 0.001) and 3.5 (95% CI: –1.6 to 8.7; P = 0.17) patients per month for hypertension and diabetes, respectively. Conclusions: Implementation of an integrated hypertension and diabetes model based on HEARTS was generally feasible and acceptable in the Ministry of Health in Guatemala. Findings can refine national scale-up in Guatemala and inform HEARTS implementation projects in other settings.
Introduction: There has been no nationally representative diabetes survey in Guatemala. The objectives of this study are (1) To provide national estimates for the prevalence of diabetes among women of reproductive age in Guatemala and (2) To assess indicators of diabetes care, including diagnosis, treatment and control in this setting. Methods: We analysed cross-sectional household survey data from the Epidemiological Health and Nutrition Surveillance System in Guatemala, collected between August 2018 and April 2019. The sample included non-pregnant women aged 15–49 with available HbA1c data. We estimated diabetes prevalence and the care cascade. Diabetes was defined as HbA1c ≥6.5% or use of glucose-lowering medication. Treatment was defined as use of medication or receiving dietary management. Control was defined as HbA1c <7%. Results: The sample consisted of 1504 women. The overall weighted prevalence of diabetes was 5.0% (95% CI 3.8% to 6.5%). Prevalence rose sharply with age, and women aged 40–49 years had a prevalence of 13.3% (95% CI 9.4% to 18.4%). Of all women with diabetes, 45.6% (95% CI 33.6% to 58.1%) had received a diagnosis, 33.6% (95% CI 25.8% to 49.0%) were treated, and 8.0% (95% CI 3.2% to 18.9%) were controlled. Conclusions: Diabetes among reproductive-age women in Guatemala poses a major public health challenge. There is a need for multisectoral efforts to strengthen the provision of diabetes prevention, diagnosis and treatment in Guatemala.
Objectives: Most countries in Latin America have committed to adopting HEARTS, PAHO’s recommended approach for managing hypertension and diabetes in national primary care health systems. This study aimed to understand and refine a HEARTS pilot for scale-up in Guatemala. Methods: Team members conducted semi-structured interviews with 30 patients and health workers participating in a HEARTS pilot across 10 primary care facilities in Guatemala’s Ministry of Health system. Researchers analyzed interviews using a combined inductive-deductive approach alongside the Tailored Implementation in Chronic Diseases framework and used convergent mixed methods to generate meta-inferences. Results: Despite high feasibility and acceptability scores, health workers described tensions between HEARTS and competing responsibilities. Patients described rational navigation of an unreliable system, a more fitting explanation for low retention than noncompliance. Both patients and health workers understood HEARTS as another externally funded project with uncertain sustainability. Medication availability improved during the pilot, but district and facility-level incentive structures perpetuated supply unreliability. Greater absolute treatment gains for hypertension than for diabetes likely reflected health worker comfort and preexisting access to blood pressure monitoring supplies. Both patients and health workers identified education gaps. Integration of qualitative and quantitative findings suggested concrete scale-up refinements, including simplifying treatment protocols, strengthening diabetes components, focusing training on nurses, reforming central-level pharmaceutical supply policies, and securing high-level Ministry of Health commitments. Conclusions: A HEARTS pilot trial in Guatemala met pre-specified quantitative outcomes, but qualitative and mixed-methods approaches revealed key barriers. These findings will assist in refining HEARTS in Guatemala for planned national scale-up. Trial registration: ClinicalTrials.gov ( NCT06080451 )